BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Leukemia
NCI Information
Clinical Trials
Leukemia Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Leukemia Podcasts and Videos
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
CALGB 10801
Principal Investigator:
Uy, Geoffrey
Title:
A Phase II Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy Plus Dasatinib (NSC #732517, IND #73969) and Continuation Therapy with Dasatinib Alone in Newly Diagnosed Patients with Core Binding Factor Acute Myeloid Leukemia (AML)
Phase:
II
Disease Site:
Myeloid and Monocytic Leukemia
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this study is to test the safety and effectiveness of the addition of the drug dasatinib to a treatment regimen for patients with AML, and to see what effects (good and bad) dasatinib has on patients and their leukemia.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)